Arvind. Institutional Equities. Event Update BUY

Size: px
Start display at page:

Download "Arvind. Institutional Equities. Event Update BUY"

Transcription

1 Event Update Institutional Equities Arvind 3 July 2015 Reuters: ARVN.BO; Bloomberg: ARVND IN Arvind Lifestyle Inks Licencing Pact with US-based Aeropostale Arvind s subsidiary, Arvind Lifestyle Brands (ALBL), has signed a licensing agreement with Aeropostale Inc, the US-based largest youth specialty retailer. Arvind is expected to set up 30 standalone stores and 25 shop-in-shops of Aeropostale over the next three years, starting from March 2016, and aims to achieve revenue of Rs3bn in three-four years from this arrangement. The company will also launch Aeropostale e-commerce website to meet India s needs. Unlike some brands, where Arvind has to import garments and pay customs duty, the company has secured the licence to manufacture Aeropostale garments locally and therefore the margin from this venture will be high. With 40% of Indian s population below the age of 20, Arvind expects Aeropostale to be highly popular and also successful. As per Mr. R Geiger, chief executive officer of Aeropostale, India is a truly exciting retail market driven by its growing economy and vibrant youth culture. He said Aeropostale is extremely pleased to associate with Arvind Lifestyle Brands, a partner bringing great knowledge and expertise in building brands and operating licenced stores in India. Post tie-up with strong brands like Hanes, Calvin Klein, GAP, The Children s Place etc, the tie-up of Aeropostale with Arvind reaffirms the strength of brands and retail franchise built by Arvind. We expect operating margin of B&R (Brands & Retail) division to improve from 5.2% to 8.6% over FY15-FY17E owing to: 1) Power brands margin set to improve by 120bps, 2) New brands likely to turn EBITDA positive in FY16 as the company exited/trimmed lossmaking brands, 3) Restructuring of Megamart leading to significant margin expansion from 1.3% in FY15 to 4.5% in FY17E, 4) Benefit of lower or stable cotton prices, 5) Improvement in same-store sales growth (SSG) because of higher footfalls, and 6) Declining share of net store addition on a large base. If Arvind continues to acquire new brands, then there may be pressure on its operating margin in the near term, but will improve its brands portfolio and long-term revenue/profitability We continue to remain highly bullish on Arvind and have retained Buy rating on the stock with a target price of Rs354, up 30% from the current market price. Strengths developed by Arvind s B&R division in the past few years: Strong distribution footprint across retail, department stores, MBOs (multi-brand outlets) and other channels. High bargaining power with channels and strong distribution strength has led to faster ramp-up of new brands. It had a reach of 951 stores in FY15 compared to ~1,450 stores of Bata India (BIL), 649 of Reliance Fashion and Lifestyle (out of 2,621 stores of Reliance Retail), 72 of Shoppers Stop, 96 of Trent (83 Westside + 13 Zara), 134 of Pantaloon Fashion & Retail (including factory outlets), 108 of V-Mart Retail (VRL) and 75 of D-Mart (FY14). In a relatively short span, Arvind achieved a retail area of 1.59mn sqft in FY15 compared to 4.2mn sqft in case of Shoppers Stop, 2.3mn sqft of Pantaloon Fashion & Retail, 0.88mn sqft of VRL, ~2.5mn sqft of BIL and 12.5mn sqft of Reliance Retail. Arvind has mastered the learning curve of growing new brands, as 5 out of top 10 international brands in India have been built by the company. Strong go-to-market capabilities with real estate, customer relationships and a seamless supply chain. Ability to address diverse segments though a differentiated portfolio, which led to presence across market segments. Arvind already has a dominant position in many segments. Proven track record of building strong brands in India with expertise in products/design, speed-to-market, and international partnerships. With shared services in B&R division, common resources like manpower, finance etc, ready infrastructure and rationalized cost of building brands, Arvind has become the preferred partner for any new international player planning to enter India. With focused category expansion, the share of men s wear reduced from 100% in FY07 to ~55% in FY15 and the company developed new categories like women s wear, kid s wear, innerwear and accessories. Arvind has done brand extension by leveraging its existing brand equity to kid s wear, women s wear and innerwear. BUY Sector: Retail CMP: Rs272 Target Price: Rs354 Upside: 30% Jignesh Kamani, CFA jignesh.kamani@nirmalbang.com Chitvan Oza chitvan.oza@nirmalbang.com Key Data Current Shares O/S (mn) Mkt Cap (Rsbn/US$bn) 70.1/ Wk H / L (Rs) 342/199 Daily Vol. (3M NSE Avg.) 2,355,616 One Year Indexed Stock Performance Jul-14 Sep-14 Nov-14 Jan-15 Mar-15 May-15 Jul-15 ARVIND Price Performance (%) NSE CNX NIFTY INDEX 1 M 6 M 1 Yr Arvind 17.6 (3.6) 11.3 Nifty Index Source: Bloomberg Please refer to the disclaimer towards the end of the document.

2 Exhibit 1: Financial summary Y/E March (Rsmn) FY10 FY11 FY12 FY13 FY14 FY15 FY16E FY17E Revenue 32,612 40,846 49,251 52,925 68,621 78,514 88, ,513 YoY (%) EBITDA 4,099 5,296 6,022 6,874 9,340 10,129 11,498 13,683 EBITDA (%) Adj. PAT 433 1,420 2,447 2,484 3,703 3,954 4,002 5,259 FDEPS (Rs) YoY (%) RoE (%) RoCE (%) P/E (x) P/BV (x) EV/EBITDA (x) About Aéropostale Aéropostale is a mall-based specialty retailer of casual apparel and accessories, principally targeting 14 to 17-year-old young women and men through its stores and 4 to 12-year-old kids through its P.S. from Aéropostale stores. The company provides customers with a focused selection of high-quality, activeoriented, fashion and fashion basic merchandise at compelling values. It maintains control over its proprietary brands by designing, sourcing, marketing and selling all of its own merchandise. The company currently operates 914 Aéropostale stores in 50 US states and Puerto Rico, 75 stores in Canada and 97 P.S. from Aéropostale stores in 22 states. In addition, pursuant to various licencing agreements, licencees currently operate 20 Aéropostale and P.S. from Aéropostale stores in the Middle East, Asia and Europe With a strong portfolio of 31 global and Indian brands in its kitty, Arvind has not only successfully transformed itself from a commodity player in the textile industry to a B&R player, but also become a formidable player in the B&R space. Revenue share of B&R division increased from 20.3% in FY10 to 30.1% in FY15 and is expected to increase to 36.1% in FY17. Four power brands of Arvind alone are worth Rs40bn and if the company is successful in scaling up its other seven brands to power brand status, its portfolio comprising 11 power brands could be worth Rs100bn in the next three years. With improving capability and investment in garment business, asset turnover and return ratios of the textile division are also expected to improve. At the current market price, Arvind stock trades at 12.8x/7.5x FY17E P/E and EV/EBITDA, respectively, which is at a significant discount compared with other players. Strong 14.3%/25.2% consolidated/b&r revenue CAGR, respectively, aided by a 45bps improvement in operating margin, turnaround in Megamart, improvement in B&R division s operating margin from 5.2% to 8.6%, demerger of Arvind Infrastructure, working capital efficiency and a reduction in D/E ratio from 1.4x to 1.2x should drive PBT/PAT CAGR by 22.8%/15.3%, respectively, generate operating cash flow of Rs9.6bn, improve pre-tax RoCE by 191bps to 17.1% over FY15- FY17E, and calls for expansion of the valuation multiple. Based on 7.5x/15.0x FY17E EV/EBITDA, we have valued Arvind s textile/b&r businesses at EV of Rs78.2bn/Rs47.9bn, respectively. We have retained Buy rating on Arvind with a SOTP-based target price of Rs354, valuing it at 17.4x/9.2x/2.6x P/E, EV/EBITDA, and P/BV respectively, based on FY17E financials. The stock can provide a healthy 30% upside from the current market price. 2 Arvind

3 Financial statements of B&R subsidiary Exhibit 2: Income statement Y/E March (Rsmn) FY10 FY11 FY12 FY13 FY14 Net sales 5,366 7,949 11,883 12,941 17,479 % growth NA Raw material costs 2,877 4,138 6,436 6,477 9,241 Gross profit 2,489 3,811 5,448 6,464 8,238 Gross profit (%) Rent ,047 1,402 Royalty on sales Advt. & publicity costs Employee costs ,281 Other costs 1,120 1,697 2,676 2,925 3,265 Total expenditure 5,090 7,352 11,202 12,208 16,546 EBITDA % growth NA EBITDA margin (%) Depreciation EBIT Interest costs Other income Profit before tax (192) (300) Tax (1) (61) (85) Effective tax rate (%) (2.4) Net profit (131) (215) PAT margin (%) (1.0) (1.2) Exhibit 4 Key ratios Y/E March (Rsmn) FY10 FY11 FY12 FY13 FY14 Return ratios (%) RoCE RoE (5.2) (8.5) Margin ratios (%) EBITDA margin PBIT margin PBT margin (1.5) (1.7) PAT margin (1.0) (1.2) Turnover ratios Asset turnover ratio (x) Avg.inventory period (days) Avg. collection period (days) Avg. payment period (days) Ex-cash working capital (%) Solvency ratios (x) Debt-equity Interest coverage Debt/EBITDA Sales NA EBITDA NA PAT NA (100.0) 0.0 Exhibit 3: Balance sheet Y/E March (Rsmn) FY10 FY11 FY12 FY13 FY14 Equity Reserves 1,541 1,642 2,095 2,215 2,295 Net worth 1,942 2,043 2,505 2,489 2,574 Minority interest Short-term loans ,470 Long-term loans 936 1,663 2,058 3,075 4,177 Total loans 1,199 1,971 2,746 3,581 5,647 D/E (x) Deferred tax liability (8) (107) (192) Total liabilities 3,134 4,085 5,295 5,963 8,028 Gross block 2,137 2,610 3,147 3,525 4,309 Fixed asset turnover (x) Depreciation ,528 Net block 1,965 2,233 2,511 2,551 2,781 Capital work-in-progress Goodwill Long-term Investments Inventories 1,595 2,607 2,827 3,225 4,093 Inventory days Debtors 601 1,248 2,265 3,284 4,724 Debtor days Cash Loans & advances 689 1,110 1,156 1,641 2,098 Other current assets Total current assets 2,945 5,067 6,395 8,397 11,126 Creditors 1,782 2,768 3,378 4,401 4,822 Creditor days Other liabilities Provisions Total liabilities 1,794 3,224 3,962 5,004 5,879 Net current assets 1,150 1,843 2,433 3,393 5,247 Net current asset as % of sales Total assets 3,134 4,085 5,295 5,963 8,028 Exhibit 5: Key matrices Y/E March (% of net sales) FY10 FY11 FY12 FY13 FY14 Gross margin Net raw material costs Employee costs Power and fuel costs Rent Commission brokerage & discounts Royalty on sales Advertisement and publicity Sales promotion exp Contract labor Others Arvind

4 Exhibit 6: B&R division s details FY10 FY11 FY12 FY13 FY14 FY15 FY16E FY17E FY18E Revenue (Rsmn) ALBL - Brands 3,592 5,681 6,914 8,332 12,390 16,315 20,919 26,945 34,121 Power brands 3,100 5,120 6,700 7,840 10,680 13,340 16,675 20,844 26,055 Other brands ,710 2,975 4,244 6,101 8,066 ARL - Retail 3,022 3,985 5,131 5,688 6,760 7,295 8,576 10,041 12,260 Megamart 3,022 3,985 5,051 5,258 5,690 5,790 6,469 7,303 8,700 Other retail -Next, Debenhams, Arvind Store ,070 1,505 2,106 2,738 3,560 Total 6,614 9,666 12,045 14,020 19,150 23,610 29,495 36,986 46,380 ALBL - Brands Power brands Other brands (55.0) 14.0 (61.9) ARL - Retail Megamart Other retail -Next, Debenhams, Arvind Store Total EBITDA (Rsmn) ALBL - Brands ,074 1,252 2,026 2,917 3,999 Power brands ,251 1,520 1,983 2,636 3,425 Other brands 4 36 (182) (188) (177) (268) ARL - Retail (50) (24) Megamart Other retail -Next, Debenhams, Arvind Store (10) (140) (210) (99) (143) (55) (71) Total ,024 1,228 2,031 3,191 4,450 EBITDA (%) ALBL - Brands Power brands Other brands (85.0) (38.2) (10.4) (9.0) ARL - Retail (0.7) (0.3) Megamart Other retail -Next, Debenhams, Arvind Store - - (12.5) (32.6) (19.6) (6.6) (6.8) (2.0) (2.0) Total EBITDA growth (%) ALBL - Brands Power brands Other brands (107.7) (605.6) 3.3 (5.9) ARL - Retail (540.0) 53.0 (58.9) (100.0) , Megamart (540.0) 53.0 (54.0) (53.0) Other retail -Next, Debenhams, Arvind Store (52.7) 44.2 (61.8) 30.0 Total 95.0 (11.8) Like- to-like growth (%) Brands Megamart (3.8) No of stores Brands ,069 1,218 Megamart Total ,083 1,227 1,393 Brands Megamart (8.8) (15.7) (15.7) Total Store size (sqft) Brands 1, ,106 1, Megamart 3,301 3,086 3,203 3,605 4,487 5,949 6,000 6,300 6,500 Total area sqft (lakh) Brands Megamart Total Brands Megamart Total Revenue (Rs/sqft) Brands 26,806 31,930 25,336 17,337 18,390 22,140 24,797 27,059 30,057 Megamart 6,923 7,318 7,718 7,501 7,822 7,340 7,578 7,804 8,155 Total 11,593 13,379 12,989 11,866 13,667 15,474 17,377 19,148 21,063 Brands (20.7) (31.6) Megamart (2.8) 4.3 (6.2) Total (2.9) (8.6) Arvind

5 Apr-11 Apr-11 Jul-11 Jul-11 Oct-11 Oct-11 Jan-12 Jan-12 Apr-12 Apr-12 Jul-12 Jul-12 Nov-12 Nov-12 Feb-13 Feb-13 May-13 May-13 Aug-13 Aug-13 Nov-13 Nov-13 Mar-14 Mar-14 Jun-14 Jun-14 Sep-14 Sep-14 Dec-14 Dec-14 Mar-15 Mar-15 Jul-15 Jul-15 Apr-11 Apr-11 Jul-11 Jul-11 Oct-11 Oct-11 Jan-12 Jan-12 Institutional Equities Apr-12 Apr-12 Jul-12 Jul-12 Nov-12 Nov-12 Feb-13 Feb-13 May-13 May-13 Aug-13 Aug-13 Nov-13 Nov-13 Mar-14 Mar-14 Jun-14 Jun-14 Sep-14 Sep-14 Dec-14 Dec-14 Mar-15 Mar-15 Jul-15 Jul-15 Exhibit 7: One-year forward P/E band (Rs) x 18x 15x 12x 9x 6x (x) Median 8.5x Source: Nirmal Bang Institutional Equities Research Exhibit 8: One-year forward EV/EBITDA band (Rsbn) x 9x 8x 7x 6x (x) Median 6.5x 30 4 Source: Nirmal Bang Institutional Equities Research 5 Arvind

6 Financials (consolidated) Exhibit 9: Income statement Y/E March (Rsmn) FY13 FY14 FY15 FY16E FY17E FY18E Net sales 52,925 68,621 78,514 88, , ,611 % growth Raw material costs 22,272 31,241 34,939 39,472 45,135 51,982 Power & fuel costs 4,298 4,343 4,882 5,884 6,790 7,857 Staff costs 5,656 6,793 8,023 9,061 10,456 12,098 Other expenses 13,825 16,904 20,542 22,919 26,448 30,602 epensesmfgmanufac Total expenditure 46,051 59,281 68,386 77,336 88, ,539 EBITDA 6,874 9,340 10,129 11,498 13,683 16,072 % growth EBITDA margin (%) Other income Extraordinary items - (164) (543) Interest costs 3,153 3,545 3,946 4,282 4,387 4,495 Gross profit 4,526 6,326 6,571 8,104 10,218 12,526 % growth (31.1) Depreciation 2,043 2,252 2,124 2,460 2,691 2,907 Profit before tax 2,483 4,073 4,448 5,644 7,527 9,618 % growth (49.9) Tax ,072 1,637 2,258 2,886 Effective tax rate (%) Net profit 2,481 3,526 3,376 4,007 5,269 6,733 % growth (43.1) 42.1 (4.2) Minority interest (3) (13) (35) Extraordinary items - (164) (543) Adjusted PAT 2,484 3,703 3,954 4,002 5,259 6,723 % growth Exhibit 11: Balance sheet Y/E March (Rsmn) FY13 FY14 FY15 FY16E FY17E FY18E Equity 2,580 2,582 2,582 2,582 2,582 2,582 Reserves 19,959 23,248 24,656 27,875 32,321 38,200 Net worth 22,540 25,830 27,239 30,458 34,903 40,783 Minority Int Short-term loans 14,557 16,465 20,020 21,020 22,020 22,020 Long-term loans 10,051 13,455 13,941 14,641 15,441 15,441 Total loans 24,608 29,920 33,961 35,661 37,461 37,461 Deferred tax liability ,148 2,051 3,206 Liabilities 47,313 56,427 62,018 67,619 74,778 81,822 Gross block 41,591 44,775 49,868 54,668 59,808 64,603 Depreciation 15,988 17,063 19,187 21,647 24,338 27,245 Net block 25,604 27,712 30,682 33,022 35,470 37,357 Capital work-in-progress 2,076 1,347 1,300 1,640 1,794 1,938 Goodwill 1,341 1,215 1,101 1,101 1,101 1,101 Long-term Investments 678 1, Inventories 14,129 16,281 18,450 19,979 22,701 25,635 Debtors 8,735 10,093 11,658 13,737 15,852 18,341 Cash 1,856 1, ,675 1,941 2,214 Other current assets 7,915 14,028 15,147 16,878 19,477 22,536 Total current assets 32,635 42,066 46,089 52,269 59,972 68,726 Creditors 10,978 12,495 13,494 16,112 18,506 21,362 Other current liabilities 4,043 4,711 4,245 4,886 5,638 6,524 Total current liabilities 15,021 17,205 17,739 20,998 24,144 27,886 Net current assets 17,614 24,860 28,350 31,271 35,827 40,840 Total assets 47,313 56,427 62,018 67,619 74,778 81,822 Exhibit 10: Cash flow Y/E March (Rsmn) FY13 FY14 FY15 FY16E FY17E FY18E EBIT 4,831 7,088 8,005 9,038 10,992 13,165 (Inc.)/dec. in working capital (2,895) (7,439) (4,320) (2,079) (4,290) (4,740) Cash flow from operations 1,937 (351) 3,685 6,958 6,702 8,424 Other income Depreciation 2,043 2,252 2,124 2,460 2,691 2,907 Deferred liabilities (131) ,154 Interest paid (-) (3,153) (3,545) (3,946) (4,282) (4,387) (4,495) Tax paid (-) (3) (548) (1,072) (1,637) (2,258) (2,886) Dividends paid (-) (498) (708) (768) (783) (813) (844) Share in profit/(loss) of (5) (10) (10) associates Net cash from ( P&L) operations 1,003 (1,814) 1,026 4,277 3,750 5,200 Capital expenditure (-) (3,157) (3,630) (5,047) (5,140) (5,294) (4,938) Net cash after capex (2,154) (5,444) (4,021) (863) (1,544) 262 Inc./(dec.) in short-term 1,044 1,909 3,554 1,000 1,000 - borrowing Inc./(dec.) in long-term 2,281 3, borrowing Inc./(dec.) in borrowings 3,325 5,312 4,041 1,700 1,800 - (Inc.)/dec. in investments (318) (490) Minority interest Equity issue/(buyback) - (0) (0) Cash from fin.activities 3,023 4,957 4,968 1,705 1, Others (1,233) 0-0- (0)- Opening cash balance 709 1,856 1, ,675 1,941 Closing cash balance 1,856 1, ,675 1,941 2,214 Change in cash balance 1,147 (193) (830) Exhibit 12: Key ratios Y/E March FY13 FY14 FY15 FY16E FY17E FY18E Per share (Rs) EPS Book value Valuation (x) P/E P/sales P/BV EV/EBITDA EV/sales Return ratios (%) RoIC RoCE (Post tax) RoCE (Pretax) RoE Margin ratios (%) Gross margin EBITDA margin PBIT margin PBT margin PAT margin Turnover ratios Asset turnover ratio (x) Avg. inventory period (days) Avg. collection period (days) Avg. payment period (days) Solvency ratios (x) Debt-equity Interest coverage Debt/EBITDA Growth(%) Sales EBITDA PAT Arvind

7 Rating track Date Rating Market price (Rs) Target price (Rs) 29 May 2015 Buy July 2015 Buy Arvind

8 Disclaimer Stock Ratings Absolute Returns BUY > 15% ACCUMULATE -5% to15% SELL < -5% This report is published by Nirmal Bang s Institutional Equities Research desk. Nirmal Bang has other business units with independent research teams separated by Chinese walls, and therefore may, at times, have different or contrary views on stocks and markets. This report is for the personal information of the authorised recipient and is not for public distribution. This should not be reproduced or redistributed to any other person or in any form. This report is for the general information for the clients of Nirmal Bang Equities Pvt. Ltd., a division of Nirmal Bang, and should not be construed as an offer or solicitation of an offer to buy/sell any securities. We have exercised due diligence in checking the correctness and authenticity of the information contained herein, so far as it relates to current and historical information, but do not guarantee its accuracy or completeness. The opinions expressed are our current opinions as of the date appearing in the material and may be subject to change from time to time without notice. Nirmal Bang or any persons connected with it do not accept any liability arising from the use of this document or the information contained therein. The recipients of this material should rely on their own judgment and take their own professional advice before acting on this information. Nirmal Bang or any of its connected persons including its directors or subsidiaries or associates or employees or agents shall not be in any way responsible for any loss or damage that may arise to any person/s from any inadvertent error in the information contained, views and opinions expressed in this publication. Nirmal Bang Equities Private Limited (hereinafter referred to as NBEPL ) is a registered Member of National Stock Exchange of India Limited, Bombay Stock Exchange Limited. NBEPL is in the process of making an application with SEBI for registering as a Research Entity in terms of SEBI (Research Analyst) Regulations, NBEPL or its associates including its relatives/analyst do not hold any financial interest/beneficial ownership of more than 1% in the company covered by Analyst. NBEPL or its associates/analyst has not received any compensation from the company covered by Analyst during the past twelve months. NBEPL /analyst has not served as an officer, director or employee of company covered by Analyst and has not been engaged in market-making activity of the company covered by Analyst. The views expressed are based solely on information available publicly and believed to be true. Investors are advised to independently evaluate the market conditions/risks involved before making any investment decision. Access all our reports on Bloomberg, Thomson Reuters and Factset. Team Details: Name Id Direct Line Rahul Arora CEO rahul.arora@nirmalbang.com - Girish Pai Head of Research girish.pai@nirmalbang.com / 18 Dealing Ravi Jagtiani Dealing Desk ravi.jagtiani@nirmalbang.com , Pradeep Kasat Dealing Desk pradeep.kasat@nirmalbang.com /8101, Michael Pillai Dealing Desk michael.pillai@nirmalbang.com /8103, Umesh Bharadia Dealing Desk umesh.bharadia@nirmalbang.com Nirmal Bang Equities Pvt. Ltd. Correspondence Address B-2, 301/302, Marathon Innova, Nr. Peninsula Corporate Park, Lower Parel (W), Mumbai Board No. : /1; Fax. : Arvind

Power Mech Projects. Institutional Equities. 2QFY18 Result Update BUY. Strong Business Scalability Likely; Retain Buy

Power Mech Projects. Institutional Equities. 2QFY18 Result Update BUY. Strong Business Scalability Likely; Retain Buy 2QFY18 Result Update Power Mech Projects 23 November 217 Reuters: POMP.BO; Bloomberg: POWM IN Strong Business Scalability Likely; Retain Buy Power Mech Projects (PMPL) posted 2QFY18 consolidated revenues

More information

Crompton Greaves. Institutional Equities. 4QFY15 Result Update ACCUMULATE. Overseas Losses Continue; More Business Exits Likely

Crompton Greaves. Institutional Equities. 4QFY15 Result Update ACCUMULATE. Overseas Losses Continue; More Business Exits Likely 4QFY15 Result Update Crompton Greaves 29 May 2015 Reuters: CROM.BO; Bloomberg: CRG IN Overseas Losses Continue; More Business Exits Likely The 4QFY15 performance of Crompton Greaves (CGL) was below expectation

More information

Institutional Equities

Institutional Equities 3QFY15 Result Update Institutional Equities GlaxoSmithKline Consumer Healthcare Reuters: GLSM.BO; Bloomberg: SKB IN 4 February 2015 Price Hike Leads To Sales Growth Glaxo SmithKline Consumer Healthcare

More information

Bajaj Electricals. Institutional Equities. 3QFY15 Result Update

Bajaj Electricals. Institutional Equities. 3QFY15 Result Update 3QFY15 Result Update Institutional Equities Bajaj Electricals 13 February 2015 Reuters: BJEL.BO; Bloomberg: BJE IN Final Phase Of Transition Pain; Retain Buy Bajaj Electricals (BJE) posted 3QFY15 revenue

More information

Swaraj Engines. Institutional Equities. 2QFY18 Result Update ACCUMULATE

Swaraj Engines. Institutional Equities. 2QFY18 Result Update ACCUMULATE 2QFY18 Result Update Institutional Equities Swaraj Engines 13 November 2017 Reuters: SWAR.BO; Bloomberg: SWE IN Strong Realisation Drives Earnings Growth Swaraj Engines (SEL) 2QFY18 earnings were 5% above

More information

Timken India. Institutional Equities. 4QFY16 Result Update BUY. Margin Expansion Leads To Huge Growth In Profit; Retain Buy

Timken India. Institutional Equities. 4QFY16 Result Update BUY. Margin Expansion Leads To Huge Growth In Profit; Retain Buy 4QFY16 Result Update Institutional Equities Timken India 23 May 2016 Reuters: TMKN.BO; Bloomberg: TIMK IN Margin Expansion Leads To Huge Growth In Profit; Retain Buy Timken India (TIL), the leading manufacturer

More information

Institutional Equities

Institutional Equities Management Meet Update Institutional Equities Kaya Reuters: KAYA.NS; Bloomberg: KAYA IN We interacted with the management of Kaya at an investor conference held by us recently. Following are the key takeaways:

More information

CARE Ratings. Institutional Equities. 2QFY18 Result Update BUY

CARE Ratings. Institutional Equities. 2QFY18 Result Update BUY 2QFY18 Result Update Institutional Equities CARE Ratings 17 November 217 Reuters: CREI.BO; Bloomberg: CARE IN Mixed Performance CARE Ratings (CARE) reported an increase of 12.3% in revenues for 2QFY18

More information

Bata India. Institutional Equities. Management Meet Update. On Right Track ACCUMULATE. Sector: Retail CMP: Rs692 Target Price: 696 Upside: 1%

Bata India. Institutional Equities. Management Meet Update. On Right Track ACCUMULATE. Sector: Retail CMP: Rs692 Target Price: 696 Upside: 1% Management Meet Update Bata India Reuters: BATA.BO; Bloomberg: BATA IN On Right Track We had a meeting recently with Mr. R. K. Gupta, Chief Financial Officer (CFO) of Bata India (BIL) to understand recent

More information

Institutional Equities

Institutional Equities 2QFY18 Result Update Institutional Equities KCP 5 December 2017 Reuters: KCP.BO; Bloomberg: KCPL IN Other Income Drives PAT; High International Coal Price Is Cause For Concern KCP reported a weak set of

More information

Institutional Equities

Institutional Equities Company Update Institutional Equities Dr. Reddy s Laboratories 5 September 2017 Reuters: REDY.BO; Bloomberg: DRRD IN Suboxone Generic Opportunity To Be Lucrative, Can Sustain For Longer Time The district

More information

Crisil. Institutional Equities. 3QCY17 Result Update ACCUMULATE. Weak SME Rating Revenues & Currency Movement Play Spoilsport

Crisil. Institutional Equities. 3QCY17 Result Update ACCUMULATE. Weak SME Rating Revenues & Currency Movement Play Spoilsport 3QCY17 Result Update Institutional Equities Crisil 18 October 2017 Reuters: CRSL.BO; Bloomberg: CRISIL IN Weak SME Rating Revenues & Currency Movement Play Spoilsport Crisil s 3QCY17 performance was below

More information

La Opala RG. Institutional Equities. 4QFY17 Result Update UNDER REVIEW. Revenues Soar, But Margins Take A Hit. Sector: Tableware CMP: Rs536

La Opala RG. Institutional Equities. 4QFY17 Result Update UNDER REVIEW. Revenues Soar, But Margins Take A Hit. Sector: Tableware CMP: Rs536 4QFY17 Result Update La Opala RG 11 May 217 Reuters: LAOP.BO; Bloomberg: LOG IN Revenues Soar, But Margins Take A Hit La Opala RG (LORL) reported revenues of Rs761mn for 4QFY17, up 41% YoY. The stellar

More information

Cadila Healthcare. Institutional Equities. 3QFY15 Result Update UNDER REVIEW. Stable Performance. Sector: Pharmaceuticals CMP: Rs1,514

Cadila Healthcare. Institutional Equities. 3QFY15 Result Update UNDER REVIEW. Stable Performance. Sector: Pharmaceuticals CMP: Rs1,514 3QFY15 Result Update Institutional Equities Cadila Healthcare 11 February 2015 Reuters: CADI.BO; Bloomberg: CDH IN Stable Performance Cadila Healthcare s (CHL) 3QFY15 earnings were in line with our expectations

More information

Swiss Glascoat Equipments

Swiss Glascoat Equipments Management Meet Update Institutional Equities Swiss Glascoat Equipments 28 December 17 Reuters: SWGE.BO; Bloomberg: SWGE IN We had a meeting with the management of Swiss Glascoat Equipments (SGEL) recently

More information

Gillette India. Institutional Equities. 2QFY19 Result Update BUY. Marketing Investments Mask Improved Top-line Performance

Gillette India. Institutional Equities. 2QFY19 Result Update BUY. Marketing Investments Mask Improved Top-line Performance 2QFY19 Result Update Gillette India 13 February 2019 Reuters: GILE.NS; Bloomberg: GILL IN Marketing Investments Mask Improved Top-line Performance Gillette India s (GILL) 2QFY19 operating and net earnings

More information

JBF Industries. Institutional Equities. 1QFY16 Result Update BUY. Healthy Gross Profit Growth, But Other Costs Higher; Retain Buy

JBF Industries. Institutional Equities. 1QFY16 Result Update BUY. Healthy Gross Profit Growth, But Other Costs Higher; Retain Buy 1QFY16 Result Update Institutional Equities JBF Industries 12 August 215 Reuters: JBFI.BO; Bloomberg: JBF IN Healthy Gross Profit Growth, But Other Costs Higher; Retain Buy Following the decline in crude

More information

3,746 2,551 3, NIM

3,746 2,551 3, NIM 4QFY17 Result Update Institutional Equities Capital First 11 May 2017 Reuters: CAPF.BO; Bloomberg: CAFL IN Net Interest Income Up, But Offset By Elevated Credit Costs Although the net interest income or

More information

V-Guard Industries. Institutional Equities. Conference-call Update BUY. Sector: White Goods CMP: Rs914 Target Price: Rs1,109 Upside: 21%

V-Guard Industries. Institutional Equities. Conference-call Update BUY. Sector: White Goods CMP: Rs914 Target Price: Rs1,109 Upside: 21% Conference-call Update Institutional Equities V-Guard Industries 7 November 214 Reuters: VGUA.NS; Bloomberg: VGRD IN We hosted the conference-call of V-Guard Industries (VIL) on 5 November 214 to discuss

More information

E&P To Stay Strong; Consumer Segment To Revive

E&P To Stay Strong; Consumer Segment To Revive Management Meet Update Institutional Equities Bajaj Electricals 30 August 2017 Reuters: BJEL.BO; Bloomberg: BJE IN E&P To Stay Strong; Consumer Segment To Revive We had a meeting with the management of

More information

EBITDA 5,019 4,211 5, EBITDA

EBITDA 5,019 4,211 5, EBITDA Result Update Institutional Equities Dalmia Bharat Reuters: DALA.BO; Bloomberg: DBEL IN Outperformance Likely To Continue Dalmia Bharat (DBL) reported a good set of numbers for, given the challenging environment

More information

Punjab National Bank

Punjab National Bank 4QFY15 Result Update Institutional Equities Punjab National Bank 11 May 2015 Reuters: PNB.BO; Bloomberg: PNB IN Asset Quality Disappointment Continues Punjab National Bank (PNB) posted dismal 4QFY15 performance,

More information

Colgate-Palmolive (India)

Colgate-Palmolive (India) Result Update Colgate-Palmolive (India) 27 July 218 Reuters: COLG.BO; Bloomberg: CLGT IN Tough Times Continue Colgate-Palmolive (India) or CLGT reported a mixed earnings performance in. Volume and revenue

More information

Sun Pharmaceutical Industries

Sun Pharmaceutical Industries Event Update Institutional Equities Sun Pharmaceutical Industries Reuters: SUN.BO; Bloomberg: SUNP IN Surprise Audit Of Halol Unit By USFDA - Outcome Is Key As per a report in the Business Standard newspaper

More information

Gillette India. Institutional Equities. 1QFY18 Result Update

Gillette India. Institutional Equities. 1QFY18 Result Update 1QFY18 Result Update Institutional Equities Gillette India 14 November 2017 Reuters: GILE.NS; Bloomberg: GILL IN Robust Growth In Operating Margin Gillette India s or GIL s overall top-line performance

More information

Punjab National Bank

Punjab National Bank 1QFY16 Result Update Institutional Equities Punjab National Bank 29 July 2015 Reuters: PNB.BO; Bloomberg: PNB IN Some Respite On Asset Quality Front Punjab National Bank (PNB) reported moderate 1QFY16

More information

Jamna Auto Industries

Jamna Auto Industries 2QFY19 Result Update Institutional Equities Jamna Auto Industries Reuters: JMNA.NS; Bloomberg: JMNA IN Performance Below Expectations; Retain Buy Due To Strong Outlook Jamna Auto s 2QFY19 earnings were

More information

9,251 7,812 8, NIM

9,251 7,812 8, NIM 4QFY15 Result Update Institutional Equities IndusInd Bank 17 April 2015 Reuters: INBK.BO; Bloomberg: IIB IN Yet Another Robust Performance IndusInd Bank s 4QFY15 profit beat our estimate by 12%. Its bottom-line

More information

9,807 8,007 9, NIM

9,807 8,007 9, NIM 1QFY16 Result Update Institutional Equities IndusInd Bank Reuters: INBK.BO; Bloomberg: IIB IN Yet Another Stellar Performance IndusInd Bank s 1QFY16 profit beat our estimate by 4%. Its bottom-line grew

More information

Bata India. Institutional Equities. 1QFY19 Result Update BUY

Bata India. Institutional Equities. 1QFY19 Result Update BUY 1QFY19 Result Update Institutional Equities Bata India 23 July 2018 Reuters: BATA.BO; Bloomberg: BATA IN Strong Margin Improvement To Drive Consensus EPS Upgrade Bata India s (BIL) YoY net sales growth

More information

Muthoot Finance. Institutional Equities. 2QFY18 Result Update BUY

Muthoot Finance. Institutional Equities. 2QFY18 Result Update BUY 2QFY18 Result Update Institutional Equities Muthoot Finance 10 November 2017 Reuters: MUTT.BO; Bloomberg: MUTH IN Gold Loan Business Really Glitters Strong profitability numbers of Muthoot Finance (MFL)

More information

La Opala RG. Institutional Equities. 1QFY18 Result Update

La Opala RG. Institutional Equities. 1QFY18 Result Update 1QFY18 Result Update La Opala RG 31 August 2017 Reuters: LAOP.BO; Bloomberg: LOG IN Flattish YoY Performance La Opala RG (LORL) reported revenues of Rs475mn for 1QFY18, up 0.6% YoY, but significantly below

More information

Muthoot Finance. Institutional Equities. 1QFY18 Result Update. Gold Loan Business Continues To Glitter BUY. 10 August 2017

Muthoot Finance. Institutional Equities. 1QFY18 Result Update. Gold Loan Business Continues To Glitter BUY. 10 August 2017 1QFY18 Result Update Institutional Equities Muthoot Finance 10 August 2017 Reuters: MUTT.BO; Bloomberg: MUTH IN Gold Loan Business Continues To Glitter Strong profitability numbers of Muthoot Finance (MFL)

More information

93,707 77,814 90, NIM

93,707 77,814 90, NIM 1QFY18 Result Update Institutional Equities HDFC Bank Reuters: HDBK.BO; Bloomberg: HDFCB IN Higher Fee Income Offsets Higher Provisioning HDFC Bank s net interest income or NII grew 20% in 1QFY18 driven

More information

ITC. Institutional Equities. 4QFY18 Result Update. Tracking Expectations ACCUMULATE. Sector: FMCG CMP: Rs286 Target Price: Rs290 Upside: 1%

ITC. Institutional Equities. 4QFY18 Result Update. Tracking Expectations ACCUMULATE. Sector: FMCG CMP: Rs286 Target Price: Rs290 Upside: 1% 4QFY18 Result Update Institutional Equities ITC 17 May 2018 Reuters: ITC.NS; Bloomberg: ITC IN Tracking Expectations ITC s growth in 4QFY18 was modest and in line with expectations. On the revenue side,

More information

Power Mech Projects. Institutional Equities. 2QFY19 Result Update BUY. Strong Order Book Drives Robust Execution

Power Mech Projects. Institutional Equities. 2QFY19 Result Update BUY. Strong Order Book Drives Robust Execution 2QFY19 Result Update Power Mech Projects 21 November 218 Reuters: POMP.BO; Bloomberg: POWM IN Strong Order Book Drives Robust Execution Power Mech Projects (PMPL) posted 2QFY19 consolidated revenues of

More information

Atul Auto. Institutional Equities. Management Meet Update ACCUMULATE. Sector: Automobile CMP: Rs445 Target Price: Rs489 Upside: 10% 23 August 2017

Atul Auto. Institutional Equities. Management Meet Update ACCUMULATE. Sector: Automobile CMP: Rs445 Target Price: Rs489 Upside: 10% 23 August 2017 Management Meet Update Atul Auto 23 August 2017 Reuters: ATUL.BO; Bloomberg: ATUL IN We had a meeting with the management of Atul Auto (AAL) recently to gauge its performance in the aftermath of a relatively

More information

Sanofi India. Institutional Equities. 3QCY18 Result Update. Robust Performance BUY

Sanofi India. Institutional Equities. 3QCY18 Result Update. Robust Performance BUY 3QCY18 Result Update Institutional Equities Sanofi India Reuters: SANO.BO; Bloomberg: SANL IN Robust Performance Sanofi India s revenues in 3QCY18 stood at Rs7,438mn which were above our/consensus estimate

More information

Nestle India. Institutional Equities. 1QCY18 Result Update. Resurgence Continues BUY. Sector: FMCG CMP: Rs8,981 Target Price: Rs10,700 Upside: 19%

Nestle India. Institutional Equities. 1QCY18 Result Update. Resurgence Continues BUY. Sector: FMCG CMP: Rs8,981 Target Price: Rs10,700 Upside: 19% 1QCY18 Result Update Institutional Equities Nestle India 11 May 218 Reuters: NEST.BO; Bloomberg: NEST IN Resurgence Continues Nestle India (NEST) reported strong overall performance during 1QCY18 driven

More information

Indian Oil Corporation

Indian Oil Corporation 3QFY18 Result Update Institutional Equities Indian Oil Corporation 1 February 2018 Reuters: IOC.BO; Bloomberg: IOCL IN Earnings Outperformance On Account Of Inventory Gains Indian Oil Corporation (IOCL)

More information

Institutional Equities

Institutional Equities 4QFY18 Result Update Institutional Equities Atul Auto 30 May 2018 Reuters: ATUL.BO; Bloomberg: ATUL IN Higher Expenses Mar Profitability Atul Auto s (AAL) 4QFY18 earnings missed our expectations on account

More information

EBITDA 5,076 3, , EBITDA

EBITDA 5,076 3, , EBITDA Result Update Ambuja Cements 21 February 218 Reuters: ABUJ.BO; Bloomberg: ACEM IN Healthy Volume Growth, Operating Costs Under Control Ambuja Cements (ACEM) reported a good set of numbers for owing to

More information

Thermax. Institutional Equities. 3QFY18 Result Update. Healthy Execution, But Margins Disappoint SELL

Thermax. Institutional Equities. 3QFY18 Result Update. Healthy Execution, But Margins Disappoint SELL 3QFY18 Result Update Institutional Equities Thermax 8 February 2018 Reuters: THMX.BO; Bloomberg: TMX IN Healthy Execution, But Margins Disappoint Thermax posted healthy execution in 3QFY18 with standalone

More information

FY11 FY12 FY13E FY14E

FY11 FY12 FY13E FY14E Plant Visit Note Institutional Equities JBF Industries 10 October 2012 Reuters: JBFI.BO; Bloomberg: JBF IN We paid a visit to the plants of JBF Industries at Silvassa, Dadra & Nagar Haveli and also at

More information

Voltas. Institutional Equities. Management Meet Update ACCUMULATE. Sector: Capital Goods CMP: Rs309 Target Price: Rs325 Upside: 5% 23 December 2016

Voltas. Institutional Equities. Management Meet Update ACCUMULATE. Sector: Capital Goods CMP: Rs309 Target Price: Rs325 Upside: 5% 23 December 2016 Management Meet Update Institutional Equities Voltas Reuters: VOLT.BO; Bloomberg: VOLT IN We had a meeting with the management of Voltas recently to get the latest business update. While the management

More information

Manappuram Finance. Institutional Equities. 3QFY17 Result Update BUY

Manappuram Finance. Institutional Equities. 3QFY17 Result Update BUY 3QFY17 Result Update Institutional Equities Manappuram Finance 9 February 2017 Reuters: MNFL.BO; Bloomberg: MGFL IN Profitability Beats Expectations Amid Some Spike In Loan Delinquency Strong Profit &

More information

KEC International. Institutional Equities. Management Meet Update BUY. On Course Towards Recovery In Operating Margin

KEC International. Institutional Equities. Management Meet Update BUY. On Course Towards Recovery In Operating Margin Management Meet Update Institutional Equities KEC International Reuters: KECL.BO; Bloomberg: KECI IN On Course Towards Recovery In Operating Margin We had a meeting with the management of KEC International

More information

Voltas. Institutional Equities. 1QFY19 Result Update. EMPS Shines, UCP Proves Its Mettle Again ACCUMULATE

Voltas. Institutional Equities. 1QFY19 Result Update. EMPS Shines, UCP Proves Its Mettle Again ACCUMULATE 1QFY19 Result Update Voltas 13 August 218 Reuters: VOLT.BO; Bloomberg: VOLT IN EMPS Shines, UCP Proves Its Mettle Again Voltas reported consolidated revenues of Rs21.5bn for 1QFY19, up 11% YoY and 5%/6%

More information

Punjab National Bank

Punjab National Bank 1QFY18 Result Update Institutional Equities Punjab National Bank 3 August 2017 Reuters: PNB.BO; Bloomberg: PNB IN Asset Quality Continues To Disappoint Punjab National Bank s (PNB) annualised loan slippage

More information

Dalmia Bharat Enterprises

Dalmia Bharat Enterprises Result Update Dalmia Bharat Enterprises 1 November 218 Reuters: DALA.BO; Bloomberg: DBEL IN Performance In Line; Stock Under Review Post Odisha Cement Amalgamation Dalmia Bharat Enterprises (DBEL) reported

More information

Indian Oil Corporation

Indian Oil Corporation 4QFY18 Result Update Institutional Equities Indian Oil Corporation 24 May 2018 Reuters: IOC.BO; Bloomberg: IOCL IN Subdued Earnings Because Of Lower GRM and Higher Expenses Indian Oil Corporation (IOCL)

More information

NESCO. Institutional Equities. Event Update. Revenues From Bombay Exhibition Centre May Take A Hit BUY

NESCO. Institutional Equities. Event Update. Revenues From Bombay Exhibition Centre May Take A Hit BUY Event Update Institutional Equities NESCO 27 August 2018 Reuters: NSEN.NS; Bloomberg: NSE IN Revenues From Bombay Exhibition Centre May Take A Hit This event update relates to an application made on 14

More information

State Bank of India. Institutional Equities. 1QFY18 Result Update

State Bank of India. Institutional Equities. 1QFY18 Result Update 1QFY18 Result Update Institutional Equities State Bank of India 14 August 2017 Reuters: SBI.BO; Bloomberg: SBIN IN Merger With Associate Banks Accentuates The Pain State Bank of India s (SBI) annualised

More information

Institutional Equities

Institutional Equities 2QFY13 Result Update Institutional Equities Reliance Infrastructure 7 November 2012 Reuters: RELIN.BO; Bloomberg: RELI IN Project Execution On Track Reliance Infrastructure reported revenue decline of

More information

TD Power Systems. Institutional Equities. Company Update BUY

TD Power Systems. Institutional Equities. Company Update BUY Company Update Institutional Equities TD Power Systems 1 September 215 Reuters: TDPS.BO; Bloomberg: TDPS IN On The Cusp Of A Turnaround; Reiterate Buy We believe TD Power Systems (TDPS) is on the cusp

More information

Hindustan Unilever. Institutional Equities. 4QFY18 Result Update

Hindustan Unilever. Institutional Equities. 4QFY18 Result Update 4QFY18 Result Update Institutional Equities Hindustan Unilever 15 May 2018 Reuters: HLL.BO; Bloomberg: HUVR IN Reaping Rewards Of Consistency 4QFY18 was the third consecutive quarter wherein Hindustan

More information

Institutional Equities

Institutional Equities 1QFY19 Result Update Institutional Equities Aurobindo Pharma 13 August 2018 Reuters: ARBP.NS; Bloomberg: ARBP IN One-offs Impact Margin Aurobindo Pharma (APL) reported 1QFY19 revenues of Rs42,503mn which

More information

26 October 2018 Reuters: MRTI.BO; Bloomberg: MSIL IN

26 October 2018 Reuters: MRTI.BO; Bloomberg: MSIL IN 2QFY19 Result Update Maruti Suzuki India 26 October 2018 Reuters: MRTI.BO; Bloomberg: MSIL IN Better-than-expected Margins; Retain Buy Maruti Suzuki India (MSIL) s 2QFY19 earnings were 18% above our estimate

More information

Hindustan Unilever. Institutional Equities. 1QFY19 Result Update

Hindustan Unilever. Institutional Equities. 1QFY19 Result Update 1QFY19 Result Update Institutional Equities Hindustan Unilever 17 July 218 Reuters: HLL.BO; Bloomberg: HUVR IN Breakout Growth Hindustan Unilever (HUVR) has delivered strong volume led top-line growth

More information

KEC International. Institutional Equities. Management Meet Update. Healthy Order Inflow Traction Expected To Continue BUY

KEC International. Institutional Equities. Management Meet Update. Healthy Order Inflow Traction Expected To Continue BUY Management Meet Update Institutional Equities KEC International Reuters: KECL.BO; Bloomberg: KECI IN Healthy Order Inflow Traction Expected To Continue We had a meeting with the management of KEC International

More information

Apar Industries. Institutional Equities. Management Meet Update. In Turnaround Mode; Retain Buy BUY

Apar Industries. Institutional Equities. Management Meet Update. In Turnaround Mode; Retain Buy BUY Management Meet Update Institutional Equities Apar Industries Reuters: APAR.BO; Bloomberg: APR IN In Turnaround Mode; Retain Buy We had a meeting with the management of Apar Industries (Apar) recently

More information

Eicher Motors. Institutional Equities. Management Meet Update BUY. Reuters: EICH.NS; Bloomberg: EIM IN

Eicher Motors. Institutional Equities. Management Meet Update BUY. Reuters: EICH.NS; Bloomberg: EIM IN Management Meet Update Institutional Equities Eicher Motors 17 July 2018 Reuters: EICH.NS; Bloomberg: EIM IN We had a meeting with the management of Eicher Motors (EML) recently. Following are the key

More information

EBITDA 6,223 6,511 (4.4) 5, EBITDA

EBITDA 6,223 6,511 (4.4) 5, EBITDA Result Update Institutional Equities Ambuja Cements 26 July 218 Reuters: ABUJ.BO; Bloomberg: ACEM IN Performance Beats Expectations, Sustainability Is Key Challenge Ambuja Cements (ACEM) reported steady

More information

Mold-Tek Packaging. Institutional Equities. Conference Update. Promising Growth Outlook BUY

Mold-Tek Packaging. Institutional Equities. Conference Update. Promising Growth Outlook BUY Conference Update Institutional Equities Mold-Tek Packaging 20 August 2018 Reuters: MOLT.BO; Bloomberg: MTEP IN Promising Growth Outlook We recently interacted with the management of Mold-Tek Packaging

More information

Dabur India. Institutional Equities. 4QFY18 Result Update. Growth Volatility Is Still Fairly High ACCUMULATE

Dabur India. Institutional Equities. 4QFY18 Result Update. Growth Volatility Is Still Fairly High ACCUMULATE 4QFY18 Result Update Institutional Equities Dabur India 3 May 2018 Reuters: DABU.NS; Bloomberg: DABUR IN Growth Volatility Is Still Fairly High Dabur India s (DABUR) consolidated top-line performance in

More information

Persistent Systems. Institutional Equities. Management Meet Update SELL. Watson IOT Bet Risk/Reward More Muted Than Anticipated

Persistent Systems. Institutional Equities. Management Meet Update SELL. Watson IOT Bet Risk/Reward More Muted Than Anticipated Management Meet Update Institutional Equities Persistent Systems 22 June 2016 Reuters: PERS.BO; Bloomberg: PSYS IN Watson IOT Bet Risk/Reward More Muted Than Anticipated We had a meeting with Persistent

More information

Huhtamaki PPL. Institutional Equities. Management Meet Update NOT RATED. CMP: Rs186 Sector: Packaging. 16 September 2014

Huhtamaki PPL. Institutional Equities. Management Meet Update NOT RATED. CMP: Rs186 Sector: Packaging. 16 September 2014 Management Meet Update Institutional Equities Reuters: HUHT.BO; Bloomberg: HPPL IN We met the management of (formerly Paper Products). After announcement of the acquisition of Positive Packaging by two

More information

Institutional Equities

Institutional Equities 1QFY18 Result Update Institutional Equities Cipla 14 August 2017 Reuters: CIPL.NS; Bloomberg: CIPLA IN Gross Margin Improvement Is A Positive Surprise Cipla s revenues in 1QFY18 stood at Rs35,251mn, showing

More information

EBITDA 2,503 2,904 (13.8) 2,722 (8.0) EBITDA

EBITDA 2,503 2,904 (13.8) 2,722 (8.0) EBITDA 1QFY19 Result Update The Ramco Cements 3 August 218 Reuters: TRCE.BO; Bloomberg: TRCL IN Challenging Business Environment Aptly Handled The Ramco Cements (TRCL) reported a stable operating performance

More information

IFB Industries. Institutional Equities. 3QFY18 Result Update. Healthy Revenues, Strong Gross Margin; Retain Buy BUY.

IFB Industries. Institutional Equities. 3QFY18 Result Update. Healthy Revenues, Strong Gross Margin; Retain Buy BUY. 3QFY18 Result Update Institutional Equities IFB Industries Reuters: IFBI.BO; Bloomberg: IFBI IN Healthy Revenues, Strong Gross Margin; Retain Buy IFB Industries (IFB) posted a healthy 17% YoY rise in net

More information

Tata Consultancy Services

Tata Consultancy Services 4QFY15 Result Update Institutional Equities Tata Consultancy Services Reuters: TCS.BO; Bloomberg: TCS IN 17 April 215 Standalone P/E to crunch; P/E premium will depend on peers Tata Consultancy Services

More information

Institutional Equities

Institutional Equities 1QFY19 Result Update Institutional Equities Dr. Reddy s Laboratories 27 July 2018 Reuters: REDY.BO; Bloomberg: DRRD IN Drug Pipeline In Place, But Regulatory Hurdles Testing Patience Dr. Reddy s Laboratories

More information

Relaxo Footwear. Institutional Equities. Management Meet Update NOT RATED. Sector: Footwear CMP: Rs December 2013

Relaxo Footwear. Institutional Equities. Management Meet Update NOT RATED. Sector: Footwear CMP: Rs December 2013 Management Meet Update Relaxo Footwear Reuters: RLXO.BO; Bloomberg: RLXF IN We had a meeting recently with Mr Sushil Batra, chief financial officer of Relaxo Footwear (RFL). Following are the key highlights:

More information

Dabur India. Institutional Equities. 1QFY19 Result Update

Dabur India. Institutional Equities. 1QFY19 Result Update 1QFY19 Result Update Institutional Equities Dabur India 2 August 2018 Reuters: DABU.NS; Bloomberg: DABUR IN Consistency Is Key To The Game Dabur India s (DABUR) operating performance in 1QFY19 was better

More information

Punjab National Bank

Punjab National Bank Company Update Punjab National Bank 19 September 2018 Reuters: PNB.BO; Bloomberg: PNB IN Concerns Remain; Assign Accumulate We take Punjab National Bank (PNB) out from Under Review and assign an Accumulate

More information

TVS Motor Company. Institutional Equities. 3QFY19 Result Update SELL

TVS Motor Company. Institutional Equities. 3QFY19 Result Update SELL 3QFY19 Result Update TVS Motor Company 23 January 2019 Reuters: TVSM.BO; Bloomberg: TVSL IN Better-Than-Expected Margins TVS Motor Company s 3QFY19 performance was above our expectations as it reported

More information

Punjab National Bank

Punjab National Bank 4QFY18 Result Update Institutional Equities Punjab National Bank 16 May 2018 Reuters: PNB.BO; Bloomberg: PNB IN Prompt Corrective Action Looms Punjab National Bank (PNB) reported its 4QFY18 results with

More information

Whirlpool of India. Institutional Equities. Analyst Meet Update. Aims To Sustain Strong Growth Trajectory; Retain Buy BUY

Whirlpool of India. Institutional Equities. Analyst Meet Update. Aims To Sustain Strong Growth Trajectory; Retain Buy BUY Analyst Meet Update Whirlpool of India Reuters: WHIR.BO; Bloomberg: WHIRL IN Aims To Sustain Strong Growth Trajectory; Retain Buy We attended the analyst meet held by Whirlpool of India (WIL) recently.

More information

Mangalam Cement. Institutional Equities. 3QFY18 Result Update. Higher Operating costs Hurt Performance BUY

Mangalam Cement. Institutional Equities. 3QFY18 Result Update. Higher Operating costs Hurt Performance BUY Result Update Mangalam Cement 16 February 2018 Reuters: MGLC.BO; Bloomberg: MGC IN Higher Operating costs Hurt Performance Mangalam Cement (MGC) reported a weak performance for on account of higher operating

More information

Institutional Equities

Institutional Equities Event Update Institutional Equities Aurobindo Pharma 10 September 2018 Reuters: ARBP.NS; Bloomberg: ARBP IN Acquires Dermatology and Oral Solids Businesses Of Sandoz Aurobindo Pharma s (APL) acquisition

More information

Bata India. Institutional Equities. Management Meet Update. Likely Getting Into A Virtuous Cycle BUY

Bata India. Institutional Equities. Management Meet Update. Likely Getting Into A Virtuous Cycle BUY Management Meet Update Institutional Equities Bata India 25 June 2018 Reuters: BATA.BO; Bloomberg: BATA IN Likely Getting Into A Virtuous Cycle We had a meeting with the management of Bata India (BIL)

More information

Institutional Equities

Institutional Equities 3QFY18 Result Update Institutional Equities Atul Auto 15 February 2018 Reuters: ATUL.BO; Bloomberg: ATUL IN Higher Expenses Drag Profitability Atul Auto s (AAL) 3QFY18 earnings missed our expectations

More information

South Indian Bank. Institutional Equities. 4QFY18 Result Update. Asset Quality Pain To Ease Hereafter BUY. 15 May 2018

South Indian Bank. Institutional Equities. 4QFY18 Result Update. Asset Quality Pain To Ease Hereafter BUY. 15 May 2018 4QFY18 Result Update Institutional Equities South Indian Bank 15 May 2018 Reuters: SIBK.BO; Bloomberg: SIB IN Asset Quality Pain To Ease Hereafter South Indian Bank (SBL) reported 4QFY18 results with the

More information

ACC. Institutional Equities. Event Update. Capacity Expansion To Consolidate Presence In Central India ACCUMULATE

ACC. Institutional Equities. Event Update. Capacity Expansion To Consolidate Presence In Central India ACCUMULATE Event Update Institutional Equities ACC 19 December 218 Reuters: ACC.BO; Bloomberg: ACC IN Capacity Expansion To Consolidate Presence In Central India ACC has announced 5.9mt capacity expansion by adding

More information

Hindustan Unilever. Institutional Equities. 2QFY19 Result Update

Hindustan Unilever. Institutional Equities. 2QFY19 Result Update 2QFY19 Result Update Institutional Equities Hindustan Unilever 15 October 2018 Reuters: HLL.BO; Bloomberg: HUVR IN Best Proxy In A VUCA World Hindustan Unilever s (HUVR) overall performance in 2QFY19 was

More information

EBITDA 1,548 1,814 (14.7) 1,561 (0.8) EBITDA

EBITDA 1,548 1,814 (14.7) 1,561 (0.8) EBITDA Result Update The India Cements 12 November 218 Reuters: ICMN.BO; Bloomberg: ICEM IN Lackluster Performance The India Cements (ICEM) reported a listless operating performance in because of the sustained

More information

Just Dial. Institutional Equities. Management Meet Update BUY. Sector: Internet Services CMP: Rs1,355 Target Price: Rs2,137 Upside: 58% 25 March 2015

Just Dial. Institutional Equities. Management Meet Update BUY. Sector: Internet Services CMP: Rs1,355 Target Price: Rs2,137 Upside: 58% 25 March 2015 Management Meet Update Institutional Equities Just Dial Reuters: JUST.BO; Bloomberg: JUST IN We had a meeting with Mr. V.S.S. Mani, chief executive officer and managing director of Just Dial (JDL) to understand

More information

The Ramco Cements. Institutional Equities. Event Update BUY

The Ramco Cements. Institutional Equities. Event Update BUY Event Update The Ramco Cements 21 December 2018 Reuters: TRCE.BO; Bloomberg: TRCL IN Capacity Expansion To Boost Its Presence In Andhra & Telangana The Ramco Cements (TRCL) has announced 3.15mt cement

More information

Hindustan Unilever. Institutional Equities. 3QFY18 Result Update BUY

Hindustan Unilever. Institutional Equities. 3QFY18 Result Update BUY 3QFY18 Result Update Institutional Equities Hindustan Unilever 18 January 2018 Reuters: HLL.BO; Bloomberg: HUVR IN Robust Performance Maintained Hindustan Unilever or HUL reported a robust set of numbers

More information

Tech Mahindra. Institutional Equities. Company Interaction & Event Update SELL

Tech Mahindra. Institutional Equities. Company Interaction & Event Update SELL Company Interaction & Event Update Institutional Equities Tech Mahindra 7 March 2017 Reuters: TEML.BO; Bloomberg: TECHM IN Broadly Maintain Our Outlook On Organic Growth And Margins We interacted with

More information

PNB Housing Finance. Institutional Equities. 4QFY18 Result Update BUY. Continued Display of Embedded Scalability. 4 May 2018

PNB Housing Finance. Institutional Equities. 4QFY18 Result Update BUY. Continued Display of Embedded Scalability. 4 May 2018 4QFY18 Result Update Institutional Equities PNB Housing Finance 4 May 2018 Reuters: PNBH.NS; Bloomberg: PNBHOUSI IN Continued Display of Embedded Scalability PNB Housing Finance (PNBHF) reported 4QFY18

More information

Dalmia Bharat Enterprises

Dalmia Bharat Enterprises Result Update Dalmia Bharat Enterprises Reuters: DALA.BO; Bloomberg: DBEL IN 22 May 218 Healthy Performance Led By Good Volume Growth Dalmia Bharat Enterprises (DBEL) reported a healthy performance for

More information

Karnataka Bank. Institutional Equities. 4QFY18 Result Update. Plucky Bank And Low Hanging Fruit BUY. 17 May Reuters: KBNK.NS; Bloomberg: KBL IN

Karnataka Bank. Institutional Equities. 4QFY18 Result Update. Plucky Bank And Low Hanging Fruit BUY. 17 May Reuters: KBNK.NS; Bloomberg: KBL IN 4QFY18 Result Update Institutional Equities Karnataka Bank 17 May 2018 Reuters: KBNK.NS; Bloomberg: KBL IN Plucky Bank And Low Hanging Fruit Karnataka Bank (KBL) reported 4QFY18 results with the key strategic

More information

Colgate-Palmolive. Institutional Equities. Management Meet Update. Structural Story Strong As Ever BUY

Colgate-Palmolive. Institutional Equities. Management Meet Update. Structural Story Strong As Ever BUY Management Meet Update Institutional Equities Colgate-Palmolive (India) Reuters: COLG.BO; Bloomberg: CLGT IN Structural Story Strong As Ever We had a meeting with the management of Colgate-Palmolive (India)

More information

Bharat Heavy Electricals

Bharat Heavy Electricals FY16 (Provisional) Result Update Institutional Equities Bharat Heavy Electricals 8 April 2016 Reuters: BHEL.BO; Bloomberg: BHEL IN Structural Headwinds Persist; Retain Sell The FY16 provisional results

More information

Sequent Scientific. Institutional Equities. 1QFY19 Result Update BUY

Sequent Scientific. Institutional Equities. 1QFY19 Result Update BUY 1QFY19 Result Update Sequent Scientific 13 August 2018 Reuters: SEQU.BO; Bloomberg: SEQ IN Regulatory Changes And Adverse Forex Movement Dampens Momentum Sequent Scientific or SSL s revenues at Rs2,369mn

More information

Hindustan Unilever. Institutional Equities. Company Update. Faster And Stronger BUY. Sector: FMCG CMP: Rs1,350 Target Price: Rs1,570 Upside: 16%

Hindustan Unilever. Institutional Equities. Company Update. Faster And Stronger BUY. Sector: FMCG CMP: Rs1,350 Target Price: Rs1,570 Upside: 16% Company Update Institutional Equities Hindustan Unilever Reuters: HLL.BO; Bloomberg: HUVR IN Faster And Stronger We reiterate our positive view on the Home and Personal Care (HPC) space and continue to

More information

Dalmia Bharat Enterprises

Dalmia Bharat Enterprises Result Update Institutional Equities Dalmia Bharat Enterprises Reuters: DALA.BO; Bloomberg: DBEL IN 14 August 218 Listless Performance, But Valuation Premium Continues Dalmia Bharat Enterprises (DBEL)

More information

Quick take. Ruchira Papers Ltd. BUY. Creating value through paper. Target Price. Investment Period 12 Months. 3 year daily price chart.

Quick take. Ruchira Papers Ltd. BUY. Creating value through paper. Target Price. Investment Period 12 Months. 3 year daily price chart. Ltd. Creating value through paper Limited (RPL) manufactures writing paper, printing paper and Kraft paper. The company's white writing and printing paper is used in making notebooks and writing material,

More information

Bata India BUY. Performance Update. CMP `1,008 Target Price `1,243. 2QFY2019 Result Update Footwear. Historical share price chart.

Bata India BUY. Performance Update. CMP `1,008 Target Price `1,243. 2QFY2019 Result Update Footwear. Historical share price chart. Nov-15 Jan-16 Apr-16 Jul-16 Oct-16 Jan-17 Apr-17 Jul-17 Oct-17 Jan-18 Apr-18 Jul-18 Oct-18 2QFY2019 Result Update Footwear November 3, 2018 Bata India Performance Update Y/E March (` cr) 2QFY19 2QFY18

More information